Multimedia
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Scientific and Medical Consultant
Adjunct Clinical Professor of Medicine
Division of Infectious Diseases
Keck School of Medicine of USC
Los Angeles, California
This program has been made available online.
Clinical Care Options (CCO) expert analysis of new HIV data from IDWeek 2021, provided by expert HIV faculty
Eric S. Daar, MD
Released: October 21, 2021
Expert selections of important HIV data from IDWeek 2021, including current and investigational ART, HIV PrEP, and metabolic outcomes of ART.
Eric S. Daar, MD
Darcy Wooten, MD
Released: October 19, 2021
Clinical Care Options (CCO) expert analysis of new data from IAS 2021: COVID-19 in PWH, 2DR, LA injectable ART, novel ART in development, and MDR TB
Joseph J. Eron, Jr., MD
Princy N. Kumar, MD, FIDSA, MACP
Eric S. Daar, MD
Shobha Swaminathan, MD
Released: October 12, 2021
Limited treatment-emergent capsid resistance occurred after 28 weeks of treatment with oral or subcutaneous lenacapavir plus FTC/TAF from ID Week 2021 reported by Clinical Care Options (CCO)
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.